Pro Share Advisors LLC Medicinova Inc Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$2.61 - $4.42 $27,303 - $46,237	-10,461 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.4 - $4.24 $35,567 - $44,354	10,461 New	10,461 $40,000
Q2 2021 Aug 13, 2021	SELL	$3.76 - $5.14 $68,443 - $93,563	-18,203 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.81 - $8.74 $8,431 - $15,321	1,753 Added 10.66%	18,203 $92,000
Q4 2020 Feb 09, 2021	BUY	$5.03 - $6.31 $82,743 - $103,799	16,450 New	16,450 $87,000
Q4 2019 Feb 12, 2020	SELL	$6.48 - $8.76 $106,440 - $143,891	-16,426 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$7.7 - $10.42 $2,825 - $3,824	-367 Reduced 2.19%	16,426 $131,000
Q2 2019 Aug 13, 2019	SELL	$8.29 - $13.22 $15,477 - $24,681	-1,867 Reduced 10.01%	16,793 $162,000
Q1 2019 May 15, 2019	BUY	$6.82 - $10.27 $1,800 - $2,711	264 Added 1.44%	18,660 $155,000
Q4 2018 Feb 14, 2019	BUY	$7.65 - $12.83 $140,729 - $236,020	18,396 New	18,396 $150,000
Q4 2017 Feb 14, 2018	SELL	$5.89 - $7.21 $129,780 - $158,865	-22,034 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$4.43 - $6.58 $6,259 - $9,297	1,413 Added 6.85%	22,034 $140,000
Q2 2017 Aug 11, 2017	BUY	N/A	20,621	20,621 $108,000

5.1M

28.5K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $62.3M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.